Gö6976 inhibits LPS-induced microglial TNFalpha release by suppressing p38 MAP kinase activation - PubMed (original) (raw)
Gö6976 inhibits LPS-induced microglial TNFalpha release by suppressing p38 MAP kinase activation
G-H Jeohn et al. Neuroscience. 2002.
Abstract
Microglial responses to endotoxin, including the synthesis of inflammatory factors, contribute to gliosis and neuron degeneration in cultured brain tissue. We have previously shown that Gö6976, a protein kinase C (PKC) inhibitor, suppressed the lipopolysaccharide (LPS)-induced production of inflammatory factors in microglia and afforded marked protection of neurons from glia-mediated cytotoxicity. The purpose of this study was to identify the signal transduction pathway underlying the neuroprotective effect of Gö6976. Gö6976 suppressed the LPS-induced release of tumor necrosis factor alpha (TNFalpha) in the microglial cell line, BV2. We show in this study the inhibitory effect of Gö6976 on TNFalpha release occurring through suppression of p38 mitogen-activated protein kinase (MAPK) phosphorylation and not through a PKC mechanism. While Gö6976 did not inhibit the activity of p38 MAPK directly, it did suppress its activation by phosphorylation, indicating the target of action of Gö6976 is a signaling event upstream of p38 MAPK. Although Gö6976 is considered a selective inhibitor of certain PKC isozymes, suppression of TNFalpha production was not mediated through inhibition of PKC activity. Gö6976 appears to play a novel role in neuroprotection by suppressing the release of pro-inflammatory factors by inhibiting the activation of p38 MAPK in microglia, rather than a PKC isoform.
Similar articles
- Gö6976 protects mesencephalic neurons from lipopolysaccharide-elicited death by inhibiting p38 MAP kinase phosphorylation.
Jeohn GH, Cooper CL, Jang KJ, Kim HC, Hong JS. Jeohn GH, et al. Ann N Y Acad Sci. 2002 May;962:347-59. doi: 10.1111/j.1749-6632.2002.tb04079.x. Ann N Y Acad Sci. 2002. PMID: 12076986 - Vitamin E suppression of microglial activation is neuroprotective.
Li Y, Liu L, Barger SW, Mrak RE, Griffin WS. Li Y, et al. J Neurosci Res. 2001 Oct 15;66(2):163-70. doi: 10.1002/jnr.1208. J Neurosci Res. 2001. PMID: 11592111 Free PMC article. - Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway.
Li Y, Liu L, Barger SW, Griffin WS. Li Y, et al. J Neurosci. 2003 Mar 1;23(5):1605-11. doi: 10.1523/JNEUROSCI.23-05-01605.2003. J Neurosci. 2003. PMID: 12629164 Free PMC article. - Regulation of myogenic activation of p38 MAPK by TACE-mediated TNFα release.
Li YP, Niu A, Wen Y. Li YP, et al. Front Cell Dev Biol. 2014 May 23;2:21. doi: 10.3389/fcell.2014.00021. eCollection 2014. Front Cell Dev Biol. 2014. PMID: 25364728 Free PMC article. Review.
Cited by
- Ameliorating effects of Gö6976, a pharmacological agent that inhibits protein kinase D, on collagen-induced arthritis.
Yoon TW, Kim YI, Cho H, Brand DD, Rosloniec EF, Myers LK, Postlethwaite AE, Hasty KA, Stuart JM, Yi AK. Yoon TW, et al. PLoS One. 2019 Dec 6;14(12):e0226145. doi: 10.1371/journal.pone.0226145. eCollection 2019. PLoS One. 2019. PMID: 31809526 Free PMC article. - β-TrCP Restricts Lipopolysaccharide (LPS)-Induced Activation of TRAF6-IKK Pathway Upstream of IκBα Signaling.
Liu J, Yuan Y, Xu J, Xiao K, Xu Y, Guo T, Zhang L, Wang J, Zheng H. Liu J, et al. Front Immunol. 2018 Dec 13;9:2930. doi: 10.3389/fimmu.2018.02930. eCollection 2018. Front Immunol. 2018. PMID: 30619291 Free PMC article. - Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK1/2 Signaling via Upregulation of Glutathione Peroxidase-1 Gene.
Tran TV, Shin EJ, Nguyen LTT, Lee Y, Kim DJ, Jeong JH, Jang CG, Nah SY, Toriumi K, Nabeshima T, Yamada K, Kim HC. Tran TV, et al. Mol Neurobiol. 2018 May;55(5):4136-4159. doi: 10.1007/s12035-017-0638-8. Epub 2017 Jun 9. Mol Neurobiol. 2018. PMID: 28597397 - Group B Streptococci Induce Proinflammatory Responses via a Protein Kinase D1-Dependent Pathway.
Upadhyay K, Park JE, Yoon TW, Halder P, Kim YI, Metcalfe V, Talati AJ, English BK, Yi AK. Upadhyay K, et al. J Immunol. 2017 Jun 1;198(11):4448-4457. doi: 10.4049/jimmunol.1601089. Epub 2017 May 1. J Immunol. 2017. PMID: 28461572 Free PMC article. - 2-cyclohexylamino-5,8-dimethoxy-1,4-naphthoquinone inhibits LPS-induced BV2 microglial activation through MAPK/NF-kB signaling pathways.
Sun HN, Shen GN, Jin YZ, Jin Y, Han YH, Feng L, Liu L, Jin MH, Luo YH, Kwon TH, Cui YD, Jin CH. Sun HN, et al. Heliyon. 2016 Jul 20;2(7):e00132. doi: 10.1016/j.heliyon.2016.e00132. eCollection 2016 Jul. Heliyon. 2016. PMID: 27512726 Free PMC article.